Filed under: Investing
Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror Expo in London
ROCKVILLE, Md.–(BUSINESS WIRE)– Emergent BioSolutions Inc. (NYS: EBS) announced its participation in the Defence against Terrorism Programme of Work (DAT POW) workshop conducted by the North Atlantic Treaty Organization (NATO) Emerging Security Challenges Division at the Counter Terror Expo in London. An initial session of the workshop was focused on the future capabilities and protection of the Special Operations Forces (SOF) community on areas such as Improvised Explosive Devices (IEDs), Intelligence, Surveillance, Reconnaissance (ISR), Biometrics and Forensics, Information Sharing Systems, Tactical Computer, Communications, Command and Control (C4), and Force Protection.
“Emergent strongly supports NATO’s initiatives to educate on protecting those who protect the population,” said Allen Shofe, Executive Vice President of Corporate Affairs, Emergent BioSolutions. “NATO DAT POW workshops are highly relevant and informative as they cover various activities undertaken and coordinated by NATO countries.”
Dr. Jamie Shea, Deputy Assistant Secretary General, NATO Emerging Security Challenges Division stated, “NATO is always looking to develop new, cutting-edge technologies and capabilities to protect troops and civilians.One of the aims of the DAT POW is to prevent non-conventional attacks, such as attacks with improvised explosive devices or mitigate other challenges such as attacks on critical infrastructure and CBRN. This workshop emphasized the importance of synergy between civilian and military organizations in order to be successful.”
The aim of the DAT POW Workshop in London was both to allow project managers to offer an overview of their projects’ deliverables, and to foster interoperability and ensure access to the latest technological developments through industry briefings and contributions. Workshop participants, including civilian and military officials representing various NATO and partner countries, discussed strategies and best practices in protecting harbors and ports, large body aircraft, countering IEDs, Explosive Ordnance Disposal and consequence management, non-lethal capabilities, ISR, Human Intelligence (HUMINT), as well as detecting, protecting against, and defeating CBRNE threats.
The Counter Terror Expo was held from April 24 to 25 in London. The Defence against Terrorism Programme of Work was developed in 2004 as a fast route to capability development and as a facilitator for Allied nations and NATO entities to take the lead in individual projects.
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty pharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us @emergentbiosolu.
About the NATO Emerging Security Challenges Division
The NATO Emerging Security Challenges Division (ESCD) within the NATO International Staff was created to deal with a growing range of non-traditional risks and challenges, such as terrorism, the proliferation of Weapons of Mass Destruction, cyber defence, and energy security. The division provides NATO with a Strategic Analysis Capability to monitor and anticipate international developments that could affect Allied security. The ESCD brings together various strands of expertise already existing in different parts of NATO Headquarters. The creation of the ESCD underlines the determination to move new, non-traditional security challenges to the centre of Allied attention. For more information, visit www.nato.int/cps/en/natolive/index.htm.
Robert G. Burrows
Vice President, Investor Relations
Vice President, Corporate Communications
KEYWORDS: United Kingdom United States Europe North America Maryland
The article Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror Expo in London originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
Powered by WPeMatico